PRU — Prudential Financial, Inc.

Q2 2026 adjusted EPS of $4.08 beat consensus near $3.35-$3.52, and several banks raised price targets, yet the broader analyst list still sits at Hold (25 hold, 7 buy, 5 sell) with a consensus target roughly 13% below the current price. The tape is not chasing the stock: RSI is neutral, price is just below its 20-day SMA, and investors remain split between strong capital return/AUM growth and international/Japan headwinds.

Reported revenue is noisy—there are clear one-off distortions in the series, like Q1 2024 at $23.6B and Q4 2024's operating loss of -$149M, so trend reading has to focus on the recovering earnings path. Operating income improved from $735M in Q1 2026 to $1,251M in Q2 2026, and EPS went from $1.71 to $2.80; versus Q2 2025, operating income is up about 69% and EPS up roughly 89%. Q3 2025's $4.01 was an outlier, but the underlying direction is an earnings inflection, not deterioration.

At $120.37, PRU trades at 10.8x trailing EPS and about 8.5x forward EPS, below its 5-year average P/E of 11.76x. P/S of 0.64 is in line with its 5-year average, P/B is 1.23, and the 4.62% dividend yield adds support. On its own history the stock is modestly cheap, not rich, but the catch is that the Street consensus target of $105.22 is below the current price, so sell-side estimates are not yet confirming the market's optimism.

The current price is roughly 14% above the $105.22 consensus target, which means the market is already pricing in further beat-and-raise quarters. TTM EPS of $11.88 and next-fiscal-year estimates of $14.24 justify the current price only if operating momentum continues; if forward estimates slip back toward trailing earnings, the stock would de-rate toward the $105-$110 area. This is a show-me setup: the cheap historical multiple alone is not the catalyst—continued earnings delivery is.

As of 2026-08-27, RSI stood at 48.95, neutral. Price was 1.54% below the 20-day SMA, 2.38% above the 50-day SMA, and 11.88% above the 200-day SMA, so the stock is range-bound/basing between the 52-week low of $91.89 and high of $127.72. Entry timing favors a pullback toward the 50-day area or a confirmed break above $127.72 rather than chasing at mid-range.

• Interest rates: higher-for-longer rates improve reinvestment yields for life insurers but also pressure fixed-income marks and compete with alternative savings products.
• Demographics/private retirement shift: the ongoing move from public pensions to personal retirement solutions is a structural tailwind for Prudential's annuities and retirement segments.
• International/Japan headwinds: product suspensions such as POJ sales and localized underwriting volatility are persistent drags on international growth.
• Competitive pressure in RILAs and IUL products: product innovation is necessary, but competition can compress spreads and slow premium growth.
• Pension risk transfer cycle: PRT volumes are lumpy, though institutional demand remains a meaningful catalyst when corporates fund pension buyouts.

• Q3 2026 earnings expected around November 4, 2026—watch adjusted operating EPS, pension risk transfer volumes, annual assumption updates, and capital return commentary.
• Capital deployment updates: Q2 2026 returned $743M via dividends and buybacks; further buyback authorizations or dividend increases would support the stock.
• New Prudential Protection IUL product could add incremental retail wealth/retirement momentum in late 2026.
• Interest-rate path: any meaningful Fed cut or sustained curve steepening changes reinvestment spreads and fixed-income portfolio marks, affecting reported book value.

• International/Japan exposure: product suspensions, currency moves, and localized underwriting volatility could keep pressuring the international segment.
• Interest rate and credit spread sensitivity: adverse moves can hit fixed-income portfolio valuations, hedging costs, and adjusted book value.
• Annual assumption updates: insurance earnings are sensitive to actuarial assumption changes, which can cause outsized quarterly swings like the Q4 2024 loss.
• Expectation risk: with price above the sell-side consensus target, a single soft quarter or guidance pullback could drive a 10-15% de-rating.

I lean bullish: PRU is a 4.6%-yielding life insurer with improving GAAP earnings, strong cash flow—Q2 2026 free cash flow was $2.35B—and a P/E below its own 5-year average. The main caveat is that the stock already trades above the average sell-side target, so the upside depends on continued beat-and-raise execution rather than just simple multiple reversion. This is analysis, not personalized advice.

I applied a 9.8x P/E to next-fiscal-year EPS of $14.237, deliberately discounting PRU's 5-year average P/E of 11.76x by roughly 17% to reflect Japan/international headwinds and the Hold consensus. This triangulates with TTM EPS of $11.877 times the historical average P/E, which gives roughly $139.68.